Hak Suk Chung

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Biotechnology and bioengineering

RSC advances

mBio

Scientific reports

Korea Institute of Science and Technology

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Korea Institute of Science and Technology Mar 01 2019

South Korea

Principal Researcher :: Center for Theragnosis

Korea University of Science and Technology

South Korea

Associate Professor :: Biological Chemistry

Korea Institute of Scinece and Technology Jun 01 2012 - Feb 28 2019

South Korea

Senior Researcher :: Center for Theragnosis

Duke University School of Medicine

United States

Postdoc :: Biochemistry

Education History

Harvard University

United States

PHD :: Chemistry and Chemical Biology

Korea University

South Korea

MSC :: Chemistry

Sookmyung Women's University Mar 01 1992

South Korea

BSC :: Chemistry

Publications

Binh Thanh Tran, Seulgi Go, Kyoung-Ran Kim, Hak Suk Chung, Dae-Ro Ahn
The positional and numerical effect of N 6 -methyladenosine in tracrRNA on the DNA cleavage activity of Cas9. RSC advances 14 (29) (2024)
Binh Thanh Tran, Seulgi Go, Kyoung-Ran Kim, Hak Suk Chung, Dae-Ro Ahn
The positional and numerical effect of N 6 -methyladenosine in tracrRNA on the DNA cleavage activity of Cas9. RSC advances 14 (29) (2024)
Hyunjung Jin, Yuhyun Ji, Jinsu An, Da Hui Ha, Ye-Ram Lee, Hye-Ji Kim, Choon Geun Lee, Wooyeon Jeong, Ick Chan Kwon, Eun Gyeong Yang, Ki Hun Kim, Chankyu Lee, Hak Suk Chung
Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant. Biotechnology and bioengineering (2024)
Hyunjung Jin, Yuhyun Ji, Jinsu An, Da Hui Ha, Ye-Ram Lee, Hye-Ji Kim, Choon Geun Lee, Wooyeon Jeong, Ick Chan Kwon, Eun Gyeong Yang, Ki Hun Kim, Chankyu Lee, Hak Suk Chung
Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant. Biotechnology and bioengineering 121 (3) (2024)
Hyunjung Jin, Yuhyun Ji, Jinsu An, Da Hui Ha, Ye-Ram Lee, Hye-Ji Kim, Choon Geun Lee, Wooyeon Jeong, Ick Chan Kwon, Eun Gyeong Yang, Ki Hun Kim, Chankyu Lee, Hak Suk Chung
Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant. Biotechnology and bioengineering 121 (3) (2024)
Jihyun Park, Seong Jae Kang, Seulgi Go, Jeongmin Lee, Jinsu An, Hak Suk Chung, Cherlhyun Jeong, Dae-Ro Ahn
Split-tracrRNA as an efficient tracrRNA system with an improved potential of scalability. Biomaterials science (2023)
Jinsu An, So Yeon Kim, Eun Gyeong Yang, Hak Suk Chung
A Fluorescence-Polarization-Based Lipopolysaccharide-Caspase-4 Interaction Assay for the Development of Inhibitors. Molecules (Basel, Switzerland) 27 (8) (2022)
Jinshi Zhao, Jinsu An, Dohyeon Hwang, Qinglin Wu, Su Wang, Robert A Gillespie, Eun Gyeong Yang, Ziqiang Guan, Pei Zhou, Hak Suk Chung
The Lipid A 1-Phosphatase, LpxE, Functionally Connects Multiple Layers of Bacterial Envelope Biogenesis. mBio 10 (3) (2019)
Jinsu An, Seong Ho Kim, Dohyeon Hwang, Kyung Eun Lee, Min Jung Kim, Eun Gyeong Yang, So Yeon Kim, Hak Suk Chung
Caspase-4 disaggregates lipopolysaccharide micelles via LPS-CARD interaction. Scientific reports 9 (1) (2019)

Hak Suk Chung.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hak Suk Chung